Located in Bridgewater, NJ, Avantor’s new Innovation Center serves as a rapid response research hub to help biopharma and pharma customers solve their drug development challenges.
Avantor has opened a new research center in Bridgewater, New Jersey to help biopharmaceutical and pharmaceutical customers with a full range of upstream and downstream processes, from gene to protein expression through final formulation and drug delivery.
With nearly 27,000 square feet of laboratory space, Avantor’s Bridgewater Innovation Center features state-of-the-art life sciences and advanced materials research tools, including cleanroom facilities, multiple mass spectrometers, specially constructed bioreactors, particle size analyzers and more.
“Our facility is distinct in that we are combining more than 100 years of expertise producing high-quality, high-purity cGMP materials with a cross-discipline of research and capabilities, all under one roof to address today’s customized drug development processes,” said Ashish Kulkarni, Avantor’s executive vice president and chief technology officer.
The facility will also be used to conduct research and development on electronics materials, with chemistries that require purity at the parts-per-trillion level.
Avantor’s Bridgewater Innovation Center is housed in the New Jersey Center of Excellence, a 110-acre life sciences campus centrally located in the northeast U.S. bioscience technology corridor. Approximately 3,000 med-tech companies are situated within a 100-mile radius. The campus is also close to major transportation routes and institutions such as Princeton University, Rutgers University and the New Jersey Institute of Technology.